JP Morgan Chase
TLX

JP Morgan Chase’s Telix Pharmaceuticals TLX Stock Holding History

JP Morgan Chase’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Buy
77,538
+20,190
+35% +$206K ﹤0.01% 4759
2026
Q1 		$514K Sell
57,348
-17,020
-23% -$130K ﹤0.01% 4994
2025
Q4 		$557K Buy
74,368
+49,013
+193% +$472K ﹤0.01% 4939
2025
Q3 		$243K Buy
+25,355
New +$311K ﹤0.01% 5417

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $15.3B AUM 25.33% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

JP Morgan Chase's TLX Position: Q2 2026 in Review

JP Morgan Chase increased its Telix Pharmaceuticals (TLX) stake by 35% in Q2 2026, buying an estimated $206K and bringing the position to 77,538 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #4759.

JP Morgan Chase first reported a position in TLX in Q3 2025 and has held it in 4 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • JP Morgan Chase held 77,538 shares of Telix Pharmaceuticals worth $876K as of Q2 2026.
  • JP Morgan Chase bought 20,190 Telix Pharmaceuticals shares in Q2 2026, an estimated $206K.
  • Telix Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4759 holding.
  • JP Morgan Chase first reported a position in Telix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.